Zobrazeno 1 - 10
of 1 371
pro vyhledávání: '"177Lu"'
Autor:
Trond Velde Bogsrud, Ola Engelsen, Thuy Thu Thi Lu, Andreas Stensvold, Derek R. Johnson, Brian J. Burkett, Ayse Tuba Kendi, Mukesh K. Pandey, Rune Sundset, Jolanta M. Durski
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Background The main objective is to discuss why treatment of non-prostate cancers with [177Lu]Lu-PSMA-radioligand achieved only low tumor dose in most published cases, despite high uptake on PSMA PET. We use a patient with renal cell carcino
Externí odkaz:
https://doaj.org/article/c7a558f85543439ab71692c0bdc3c94e
Autor:
Dheeratama Siripongsatian, Attapon Jantarato, Chetsadaporn Promteangtrong, Anchisa Kunawudhi, Peerapon Kiatkittikul, Natphimol Boonkawin, Sukanya Yaset, Sirinsuda Somboon, Chanisa Chotipanich
Publikováno v:
Indian Journal of Radiology and Imaging, Vol 34, Iss 04, Pp 579-587 (2024)
Objective [177Lu]Lu-prostate-specific membrane antigen (PSMA)-617 radioligand therapy (RLT) shows promise for metastatic castration-resistant prostate cancer (mCRPC) patients with positive PSMA positron emission tomography (PET) imaging. Identifying
Externí odkaz:
https://doaj.org/article/cfbdec4d3c9e4966b21c1811fc8c80f4
Autor:
David Ventura, Philipp Rassek, Philipp Schindler, Burak Han Akkurt, Linus Bredensteiner, Martin Bögemann, Katrin Schlack, Robert Seifert, Michael Schäfers, Wolfgang Roll, Kambiz Rahbar
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is an essential tool for patient selection before radioligand therapy (RLT). Interim-staging with PSMA-PET during RLT allows for therapy monitoring. Howeve
Externí odkaz:
https://doaj.org/article/df3f1ee603084bb3b65b7c49acbc1e64
Autor:
Leandra Piscopo, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Erica Di Donna, Stefania Clemente, Antonio Varallo, Mariano Scaglione, Alberto Cuocolo, Michele Klain
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5617-5629 (2024)
The aim of the present study was to evaluate the safety and efficacy of radionuclide therapy with [177Lu]Lu-DOTA-TATE according to our single center experience at the University of Naples Federico II. For the present analysis, we considered 21 patien
Externí odkaz:
https://doaj.org/article/a2dee3d0e61b43c9b6b706b9d0bab36d
Publikováno v:
Journal of Isotopes, Vol 37, Iss 4, Pp 394-398 (2024)
Targeted radionuclide therapy (TRT)，the use of radiopharmaceuticals to target and irradiate tumour cells，has become an important method for cancer treatment. The radiolanthanide Lutetium-177 (177Lu) is a medium-energy beta radionuclide with a sui
Externí odkaz:
https://doaj.org/article/a517cf389ae849c2a82f7d3247f5571d
Autor:
Amir Karimzadeh, Linus Schatz, Markus Sauer, Ivayla Apostolova, Ralph Buchert, Susanne Klutmann, Wencke Lehnert
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-20 (2024)
Abstract Background Internal dosimetry in individual patients is essential for safe and effective radioligand therapy. Multiple time point imaging for accurate dosimetry is time consuming and hence can be demanding for nuclear medicine departments as
Externí odkaz:
https://doaj.org/article/02f00a8c31cf47519a27e9aa9720aedc
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-17 (2024)
Abstract Background The aim was to investigate the noise and bias properties of quantitative 177Lu-SPECT with respect to the number of projection angles, and the number of subsets and iterations in the OS-EM reconstruction, for different total acquis
Externí odkaz:
https://doaj.org/article/3561377c615f4574addb5f6170b66d02
Autor:
Julian Leube, Wies Claeys, Johan Gustafsson, Maikol Salas-Ramirez, Michael Lassmann, Michel Koole, Johannes Tran-Gia
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-20 (2024)
Abstract Background Although the importance of quantitative SPECT has increased tremendously due to newly developed therapeutic radiopharmaceuticals, there are still no accreditation programs to harmonize SPECT imaging. Work is currently underway to
Externí odkaz:
https://doaj.org/article/40409978bf78464483fe6377b9b9ad6e
Publikováno v:
Journal of Isotopes, Vol 38, Iss 2, Pp 185-194 (2024)
Medical isotopes are the substantial basis of the diagnostic and therapeutic nuclear medicine. There are irreplaceable advantages for utilizing the nuclear medical technology to diagnose and treat the malignant tumors, cardiovascular and cerebrovascu
Externí odkaz:
https://doaj.org/article/15b9cf8e3f8e4983a80a18411a047ac5
Autor:
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A. Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R. Christ, Damian Wild
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Background A new generation of radiolabeled minigastrin analogs delivers low radiation doses to kidneys and are considered relatively stable due to less enzymatic degradation. Nevertheless, relatively low tumor radiation doses in patients in
Externí odkaz:
https://doaj.org/article/b2acaa6880e14783bd5cb5fd43fcbc99